WPI P (Mononessa inert)
Generic Name: ethinyl estradiol/norgestimate
Pill imprint WPI P has been identified as Mononessa inert.
Mononessa is used in the treatment of birth control; abnormal uterine bleeding; ovarian cysts; endometriosis; gonadotropin inhibition and belongs to the drug class contraceptives. Not for use in pregnancy. Mononessa inert is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- ethinyl estradiol/norgestimate
- Imprint:
- WPI P
- Strength:
- inert
- Color:
- Green
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Contraceptives
- Pregnancy Category:
- X - Not for use in pregnancy
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Watson Pharmaceuticals, Inc.
- National Drug Code (NDC):
- 52544-0247
More about Mononessa (ethinyl estradiol / norgestimate)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 173 Reviews – Add your own review/rating
- Drug class: contraceptives
Consumer resources
Other brands: Sprintec, Ortho Tri-Cyclen, TriNessa, Tri-Sprintec, More... (10)
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
